Designing Epidemiological Studies (2) Flashcards

1
Q

How can it be assessed whether an exposure is associated with an outcome?

A
  1. Experimental study

2. Observational study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is the strength of an association judged?

A

Robustness of evidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some issues with observational studies?

A

Observed groups may differ in characteristics (confounding variables)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are randomised control trials?

A

Experimental studies that compare and assess the effectiveness of 2 or more treatments to see if one is better than another
Comparative group acts as control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are placebo controlled trials?

A

Placebo (control) VS treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is intention to treat?

A

Analysing patients according to which group they were originally assigned

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the randomisation process?

A
  1. Generation of the allocation sequence

2. Implementation of the allocation (allocation concealment - single / double blind)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is performance bias?

A

Systematic differences between groups in care that is provided, or in exposure to factors other than the intervention of interest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is detection bias?

A

Systematic differences between groups in how outcomes are determined

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 2 types of literature review?

A
  1. Narrative review

2. Systematic review

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a narrative review?

A

Brings together the published literature into a single article enabling the reader to rapidly understand the issues

AKA scoping review or non-systematic review

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a systematic review?

A

Sets out a highly structures approach to searching, sifting, including and summarising the literature
Often presented as the basis for meta-analysis, but also exists separately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the strengths and weaknesses of narrative reviews?

A

Strengths: agile - easier and faster to write
Useful in areas with limited research or variations in research approaches
Useful when bringing together diverse ranges of opinions and disciplines

Weaknesses: Subject to potential bias (authors free to select works - unbalanced)
No search is specified - evidence may be omitted by chance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the strengths and weaknesses of systematic reviews?

A

Aims to collate all available evidence that relates to a highly focused research question
Implements highly specified protocol
Includes evidence based on pre-specified criteria: inclusion and exclusion criteria

Can take many months
Bad search structure - miss out literature
Only as good as the evidence they incorporate
Dating very quickly - search date not article publication date (search date may be from 18-24mo ago)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the process of a systematic review?

A
  1. Research question - narrowly defined RQ
  2. Structured search - series of search terms or phrases placed into search engine, reproducible approach
  3. Indices - e.g. medline, specify which indices are used upfront
  4. Screening / inclusion - PRISMA diagram, shows how many articles found, how many come up as duplicates, then screening of content for eligibility, then calculate how many studies are included in the final systematic review / meta-analysis
  5. Reporting
  6. Writing
  7. Submitting, peer review, revising, publishing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are registries?

Why are registries used before indices?

A

Registration of research yet to be completed or published

To avoid duplication or omission of relevant studies

17
Q

What is grey information / grey literature?

A

Not everything that is known is necessarily in the published literature online e.g. gov ports, evaluations of certain programmes, etc.

18
Q

How can grey literature be examined?

A

Do not follow structured search engines - use open grey searches e.g.
Google scholar
Open grey

19
Q

Why is referencing important??

A

Can snowball out the reviews to find the individual literatures
You can look at the individual literature to see in what other publications they have been cited

20
Q

What is the Cochrane Collaboration?

A

Brings together series of systematic reviews and meta-analyses
Decisions of health and healthcare are informed by high-quality, relevant and up-to-date synthesised research evidence

21
Q

What is meta-analysis (in the context of systematic review)

A

Uses same principles as systematic review, except uses quantitative data instead of qualitative data

A quantitative, formal, epidemiological study design used to systematically assess previous research studies to derive conclusions about that body of research

22
Q

What is the process of meta-analysis?

A

Extract results (stats) from the individual literatures, compile (add up) all the results to give better results

Pool the estimate of association (i.e. add together the no. of ppts, and results)

23
Q

How are the estimates presented? (i.e. findings of meta-analysis communicated?)

A

Forest plots
Midline = line of no effect
Square = number of ppts
Horizontal lines = confidence around each of the estimates

Higher no. of ppts = shorter horizontal lines

Position of square relative to the midline indicates what is going on (i.e. to the right = positive effect, to the left = negative effect)

Diamond = pooled estimate, combined power of individual literature findings, (right and left) corners of diamond represents confidence

24
Q

How are individual literatures weighted differently in the meta-analysis?

A

Usually dependent on size of study

25
Q

What is heterogeneity in meta-analyses?

What are the 3 sorts of heterogeneity?

A

Differences between the individual studies

Clinical = patients, selection criteria
Methodological = different study designs, blinding, intervention approaches
Statistical: reporting differences in different ways

26
Q

What is publication bias?

A

Studies with positive findings are more likely to be submitted and accepted for publication

27
Q

What are the limitations of meta-analyses?

A

Limited by the quality of the studies included, stats methods employed
Need to go back to original authors of studies to ask for more data for the meta-analysis

28
Q

What is meant by endpoint in clinical trials?

A

An outcome that usually describes a clinically meaningful outcome e.g. cancer survival

29
Q

What is the difference between safety and efficacy of a therapy?

A

Efficacy – how well a therapy works in achieving a desired outcome

Safety – how well a therapy works in not causing adverse events
30
Q

What are the 2 types of efficacy endpoints?

What are they?

A

Primary endpoint – pre-specified endpoint before the study is begun

Secondary endpoint – it is common that a study will want to examine a slightly different endpoint in addition to the primary endpoint. For example, while a study seeks to examine survival (i.e. alive or dead) another – often ‘softer’ - measure such as recurrence of disease or hospital admission might also be measured. If the secondary endpoint is proven but the primary endpoint is not, then the findings of the study may still contribute to the understanding of disease.
31
Q

What are safety endpoints?

A

Major issues e.g. anaphylaxis or direct mortality associated with the therapy
Therapy stopped at this

32
Q

What are phrase composite endpoints?

A

Composite = multiple potential endpoints have been added together
Particularly common when an outcome is uncommon
E.g. combine MI and ischaemic stroke =
cardiovascular event

33
Q

What is survival analysis?

A

Follow the two conditions in an experiment for the whole duration of the primary endpoint (E.g. survival after 5 years)
Plot when each person dies
Compare curves of both conditions